| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Dec 24 | PVCT Provectus Biopharmaceuticals | Stock Options Common Stock | Grant | Acquire A | No | No | 0.2862 | 16,146,600 | 4.62 mm | 16,146,600 |
| 30 Sep 24 | PVCT Provectus Biopharmaceuticals | Series D-1 Convertible Preferred Stock Common Stock | Grant | Acquire A | No | No | 0 | 196,250 | 0.00 | 1,337,876 |
| 25 Jun 24 | PVCT Provectus Biopharmaceuticals | Series D-1 Convertible Preferred Stock Common Stock | Grant | Acquire A | No | No | 0 | 1,141,626 | 0.00 | 1,141,626 |
| 25 Jun 24 | PVCT Provectus Biopharmaceuticals | Series D Convertible Preferred Stock Common Stock | Sale back to company | Dispose D | No | No | 0 | 11,416,242 | 0.00 | 0 |
